Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Standard Dose Influenza Vaccines in Pediatric SOT Recipients
NCT05947071Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2024
- Primary completion
- Jul 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza virus quadrivalent inactivated vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2024; status: recruiting.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05947071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05947071.